Home About us Contact
|
Home About us Contact | ||
|
|
||
Cumulative Survival Rate (cumulative + survival_rate)
Selected AbstractsCUMULATIVE SURVIVAL RATE BETWEEN ESRD PATIENTS UNDER TREATMENT HEMODIALYSIS AND KIDNEY TRANSPLANTATIONNEPHROLOGY, Issue 1 2002Aditiawardana [source] Influence of methylated p15 INK4b and p16 INK4a genes on clinicopathological features in colorectal cancerJOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Issue 8 2006Atsushi Ishiguro Abstract Background and Aim:, Genetic silencing by promoter methylation has attracted attention in the carcinogenesis of colorectal cancer. Methylation of the p16INK4a gene has been found in primary colorectal cancer. Although the p15INK4b gene displays high homology to the p16INK4a gene in the amino acid sequence, methylation of p15INK4b has not been fully studied. We investigated p15INK4b methylation status in patients with colorectal cancer to verify the association between the methylation of p15INK4b and clinicopathological features compared with p16INK4a. Methods:, DNA samples from the tissues of primary colorectal cancer and corresponding adjacent normal colon mucosa were obtained from surgical resections of 88 patients (47 males and 41 females, aged 29,83 years). Methylation-specific polymerase chain reaction was used to analyze p15INK4b and p16INK4a methylation status after bisulfite modification. Cumulative survival rates (mean follow-up period: 53.2 months) were calculated by the Kaplan-Meier analysis. Results:, Methylations of p15INK4b and p16INK4a genes were detected in 23 (26.1%) and 20 (22.7%) colorectal cancers, respectively. Methylation of p15INK4b was not associated with any clinicopathological features. Compared with normal mucosa, the methylation of p15INK4b was more prominent in tumor tissue (P < 0.001). Reverse transcription-polymerase chain reaction (RT-PCR) revealed that p15INK4b methylaton decreased mRNA expression. Kaplan-Meier analysis showed that patients with stage I-II had a significant difference in survival rate between those with and without methylated p15INK4b (P = 0.018). Conclusions:, Our results suggest that methylation of the p15INK4b gene contributes to the process of carcinogenesis in colorectal cancer as well as p16INK4a and is useful as a prognostic factor in the early stage. [source] Intra-arterial chemotherapy with mitomycin C in gallbladder cancer: A follow-up studyJOURNAL OF SURGICAL ONCOLOGY, Issue 2 2005Michaela K. Bode MD Abstract Background and Objectives There is only limited and somewhat controversial information available on hepatic artery infusion of cytotoxic agents in gallbladder cancer. We report the results of 5-year follow-up of all gallbladder cancer patients treated with surgery and intra-arterial mitomycin C or mitomycin C alone in our hospital during 15 years. Methods Thirty-five patients with gallbladder cancer were treated with superselective intra-arterial chemotherapy (SIAC) with mitomycin C during 1981,1996. Survival was measured from diagnosis, and all patients were followed up until death or the end of January 2002. Cumulative survival rates and median survival times were calculated for all patients, according to response to treatment and staging. The data are presented as 5-year survival. Results Median survival times after SIAC for all patients, responders, and non-responders were 48, 60+, and 8.5 months, respectively. Overall response rate was 60%. Survival was significantly better for tumors limited to the gallbladder wall, as expected. Drug toxicity occurred in half of the patients, requiring cessation of chemotherapy in 25% of the cases. Conclusions The median survival of gallbladder cancer patients treated with surgery and SIAC seems to be significantly better compared to the previously reported outcome of surgical treatment alone. Drug toxicity limits the use of i.a. chemotherapy and requires careful monitoring for early side-effects. J. Surg. Oncol. 2005;91:102,106. © 2005 Wiley-Liss, Inc. [source] Role of metastasectomy in the management of thyroid carcinoma: The NIH experienceJOURNAL OF SURGICAL ONCOLOGY, Issue 1 2003Ho Pak MD Abstract Background and Objectives We studied the impact of metatasectomy on disease outcome in 29 advanced nonmedullary thyroid carcinoma (ThyrCa) patients who were operated on between 1969 and 2001 at NIH to further define its role in the management of this malignancy. Methods Data were extracted by retrospective chart review. A Kaplan-Meyer survival curve was constructed, and comparative stratification for various parameters was performed. Results During 47 surgeries, the following lesions were resected from mid-mediastinum/hila, 17; lung parenchyma, 12; skeleton, 14; kidneys, 2; and brain, 2. All patients received multiple radioiodine (RAI) treatments. External-beam radiotherapy, chemotherapy and other palliative measures were used in selected patients. Six patients (21%) died within 74.7,±,54.7 months after the first distant metastasectomy. The outcome of the remaining patients was as follows: complete remission, 3; partial remission, 10; and 10: progressive disease, 10, with a follow-up of 175 patient-years. Metastasectomy led to a decrease of 38% in thyroglobulin levels in 23 patients. Cumulative survival rates were 78.5,±,8.4% at 5 years and 50.2,±,12.5% at 10 years (mean ±SEM) after initial distant metastasectomy. Conclusions Our data show that extensive targeted metastasectomy in the setting of a tertiary center can be beneficial to patients with disseminated ThyrCa with persistent or recurrent distant disease, when used in conjunction with nonsurgical treatment modalities. J. Surg. Oncol. 2003;82:10,18. © 2002 Wiley-Liss, Inc. [source] Clinical Experience of TiUniteÔ Implants: A 5-year Cross-Sectional, Retrospective Follow-Up StudyCLINICAL IMPLANT DENTISTRY AND RELATED RESEARCH, Issue 2010Bertil Friberg DDS ABSTRACT Background: Little is known of the long-term clinical and radiographic performance of moderately rough surface implants. Purpose: The aim of the present retrospective investigation was to study two pioneer cohorts of patients, that is, the first patients to receive Brånemark System® implants with a moderately rough surface (TiUniteÔ, Nobel Biocare AB, Göteborg, Sweden) at the present clinic. TiUnite implants were inserted either in compromised bone sites in a mixed-mouth concept together with turned implants or used solely. Patients were followed up over a period of 5 years with regard to implant survival and the marginal bone response. Materials and Methods: Patients who received both implant types (mixed group) comprised 41 subjects, and the second group (TiUnite group) comprised 70 subjects. A total of 110 turned and 68 TiUnite implants were placed in the mixed group, and 212 TiUnite implants in the TiUnite group. Follow-up radiographs were obtained at prosthesis placement and at the 1- and 5-year check-ups, and examined by independent observers. Results: One turned (0.9%) and two TiUnite (2.9%) implants failed in the mixed group, and three implants (1.6%) failed in the TiUnite group, indicating no significant differences between surfaces or groups (p < .05). The mean marginal bone loss at 5 years was 0.6 mm to 0.8 mm, also indicating no significant differences for the two implant types tested in the mixed group. Conclusions: Cumulative survival rates for the two implant surfaces were favorable at 5 years, and the marginal bone loss was low and similar for both implant surfaces. [source] Five-Year Survival Distributions of Short-Length (10 mm or less) Machined-Surfaced and Osseotite® ImplantsCLINICAL IMPLANT DENTISTRY AND RELATED RESEARCH, Issue 1 2004Sylvan Feldman DDS ABSTRACT Background: In cases of reduced alveolar bone height, implants of short length (10 mm or less) may be employed although there is a perceived risk that because of their small stature they will be unable to tolerate occlusal loads and will fail to osseointegrate. Purpose: This report describes an analysis of prospective multicenter clinical studies evaluating the risk for failure of short-length implants, comparing dual acid-etched (DAE) Osseotite® implants (Implant Innovations, Inc., Palm Beach Gardens, FL, USA) to machined-surfaced implants. Materials and Methods: Admission criteria were the same for both data sets. Baseline variables of demographics including age, gender and smoking status, bone quality, location, implant dimensions, and types of prostheses were compared to ensure balance among groups. Cumulative survival rates (CSRs) were calculated with the Kaplan-Meier estimator. Results: The implant data included 2,294 implants for the DAE series and 2,597 implants for the machined-surfaced series. Patient demographics showed similar percentages of occurrence for all variables. The distributions of implants between short- and standard-length data sets for baseline variables including width, location, and restorative type were similar, qualifying these data sets for comparison of the independent variable of length. Overall, there was a 2.2% difference in 5-year CSRs between the machined-surfaced short- and the standard-length implants. For these implants a 7.1% difference was observed in the posterior maxilla and an 8.5% difference in the anterior maxilla. For DAE implants the overall difference between "standards" and "shorts" was 0.7%, which is not statistically significant. Conclusion: In this analysis the difference in CSRs between short- and standard-length implants was greater for machined-surfaced implants than for DAE implants. [source] Efficacy of splenectomy for hypersplenic patients with advanced hepatocellular carcinomaHEPATOLOGY RESEARCH, Issue 12 2008Masashi Hirooka Aim:, Chemotherapy for advanced hepatocellular carcinoma (HCC) patients with hypersplenism is generally unsatisfactory, as a lower-dose therapy is usually administered. Splenectomy may represent a better approach to overcoming the complication due to hypersplenism in patients with advanced HCC. This retrospective study was conducted to evaluate whether HCC patients who undergo splenectomy show improved prognosis. Methods:, We examined 34 HCC patients. Twenty-two had thrombocytopenia and/or leucopenia and underwent laparoscopic splenectomy. The completion rate of full-dose drug regimens, the response rate, the toxicity of chemotherapy and the cumulative survival rate were compared between the splenectomy and non-splenectomy groups. Results:, The response rate and the cumulative survival rate in the splenectomy group were significantly better than that in the non-splenectomy group. Conclusions:, Splenectomy is an efficient method for advanced HCC patients with hypersplenism treated by chemotherapy. [source] The role of entecavir in preventing hepatitis B recurrence after liver transplantationJOURNAL OF DIGESTIVE DISEASES, Issue 4 2009Zhi Feng XI OBJECTIVE: Although hepatitis B recurrence after liver transplantation has been reduced to 0%,10% since the application of the combination therapy of hepatitis B immunoglobulin (HBIG) and lamivudine, the viral mutation resistance of lamivudine is still an obstacle to the outcome of liver transplantation. Here we evaluate the role of entecavir in preventing hepatitis B recurrence after liver transplantation. METHODS: Patients who received a liver transplantation for hepatitis B virus (HBV)-related end-stage liver disease in our center from March 2006 to December 2008 were enrolled in this study. All patients received entecavir (0.5 mg orally, daily) or lamivudine (100 mg orally, daily) together with a long-term low dosage of HBIG to prevent hepatitis B recurrence after transplantation. Serum viral markers (HBsAg, anti-HBs, HBeAg, anti-HBc and anti-HBe) and HBV-DNA level were determined. RESULTS: Thirty patients receiving entecavir and 90 patients receiving lamivudine were matched with the same age and sex in both groups. No reinfection of hepatitis B was detected in the entecavir group. The hepatitis B surface antigen of patients in the entecavir group became negative within one week and no patient had any adverse effect relating to entecavir. There was no difference in the cumulative survival rate between the entecavir group and the lamivudine group (P > 0.05). CONCLUSION: This study shows that entecavir combined with low dosages of HBIG is effective and safe in preventing hepatitis B recurrence after liver transplantation, but its long-term effect is still under investigation and a large-sample study will be carried out in the future. [source] Clinical evaluation of Procera AllCeram crowns in Japanese patients: results after 5 yearsJOURNAL OF ORAL REHABILITATION, Issue 11 2009Y. KOKUBO Summary, Procera AllCeram crowns were prospectively evaluated clinically in both anterior and posterior regions in Japanese. One-hundred and one crowns were fabricated for 57 patients at the Tsurumi University Dental Hospital from August 2001 to October 2002 and evaluated according to the California Dental Association (CDA) quality evaluation system at baseline and annually at all follow-up examinations for 5 years. The plaque index (PI) and gingival index (GI) were recorded, and chipping and fracture were checked at the same time as well. A total of 75 Procera AllCeram crowns were evaluated, and the cumulative survival rate was 90·2% over the 5-year clinical trial. Six crowns experienced fractures within the veneering porcelain and from aluminium oxide coping, all of which occurred on the premolar and molar regions, and they had to be removed. Small chipping was observed on three crowns. According to the CDA criteria, 98% of Procera AllCeram crowns were rated as satisfactory, and PI and GI were comparable to those of control teeth during the observation period. [source] A prospective 5-year study of fixed partial prostheses supported by implants with machined and TiO2 -blasted surfaceJOURNAL OF PROSTHODONTICS, Issue 1 2001Klaus Gotfredsen DDS Purpose The aim of the present study was to evaluate whether there was a difference between machined and TiO2 -blasted implants regarding survival rate and marginal bone loss during a 5-year observation period. Materials and Methods A total of 133 implants (Astra Tech Dental Implants; Astra Tech AB, Mölndal, Sweden) were placed in 50 patients at 6 centers in 4 Scandinavian countries. Forty-eight implants were installed in the maxilla and 85 implants in the mandible. A randomization and a stratification were done, so that each fixed partial prosthesis was supported by at least 1 machined and 1 TiO2 -blasted implant. The implant-supported fixed partial prostheses (ISFPP) were fabricated within 2 months after postoperative healing. A total of 52 ISFPP (17 maxillary, 35 mandibular) were inserted. The patients were clinically examined once a year for 5 years. At the annual follow-up, biological as well as technical complications were recorded. Results Of the 133 implants placed, 3 were reported as failed after 5 years of follow-up, resulting in an overall cumulative survival rate of 97.6%. The cumulative implant survival rates were 100% for the TiO2 -blasted implants and 95.1% for the machined implants. No significant difference in survival was, however, found between the machined and TiO2 -blasted implants after 5 years. The mean marginal bone loss in the maxilla was 0.21 ± 0.83 mm (SD) for the machined implants and 0.51 ± 1.11 mm (SD) for the TiO2 -blasted implants during the 5-year observation period. In the mandible, the mean marginal loss was 0.22 ± 1.13 mm for the machined implants and 0.52 ± 1.07 mm for the TiO2 -blasted implants from baseline to the 5-year examination. No significant difference in marginal bone loss between the 2 surface groups was found during the 5-year observation period. Conclusions The present study shows good 5-year results with small ISFPP in the mandible, as well as in the maxilla. No significant differences were found in failure rate and marginal bone loss around implants with a machined rather than a TiO2 -blasted surface. [source] The effect of spleen-preserving lymphadenectomy on surgical outcomes of locally advanced proximal gastric cancerJOURNAL OF SURGICAL ONCOLOGY, Issue 5 2009Sung Jin Oh MD Abstract Background The aim of this study was to investigate the effects of D2 lymphadenectomy with spleen preservation on surgical outcomes in locally advanced proximal gastric cancer. Methods Between January 2000 and December 2004, a total of 366 patients who underwent curative total gastrectomy were studied retrospectively from a prospectively designed database. Results The spleen-preservation group experienced shorter operation times, a lower incidence of perioperative transfusion, and shorter postoperative hospital stays. Perioperative transfusion and splenectomy were independent risk factors for morbidity. There was no significant difference between the two groups in recurrence or cumulative survival rate when adjusted according to cancer stage. Multivariate analysis showed that tumor size, serosal invasion, and nodal metastasis were independent prognostic factors, while splenectomy was not. The cumulative survival rate in pN0-status patients was significantly higher in the spleen-preservation group, while there was no significant difference in the survival of pN1- or pN2-status patients between the two groups. Conclusions Splenectomy for lymph node dissection in proximal gastric cancer patients obviously showed poor short-surgical outcomes, but it did not affect long-term outcomes in terms of recurrence and overall survival rate. Therefore, spleen-preserving lymphadenectomy is a feasible method for radical surgery in locally advanced proximal gastric cancer. J. Surg. Oncol. 2009;99:275,280. © 2009 Wiley-Liss, Inc. [source] Significance of CT Attenuation Value in Liver Grafts Following Right Lobe Living-Donor Liver TransplantationAMERICAN JOURNAL OF TRANSPLANTATION, Issue 5 2005Taku Iida In adult living-donor liver transplantation (LDLT), the assessment of the allograft functional reserve is important for adequate graft regeneration. From March 2002 to December 2003, 30 adult recipients underwent right lobe LDLT. Mean CT attenuation values (CT-AVs) in the graft were measured on unenhanced CT for 6 months after LDLT. The histological features of the graft parenchyma were evaluated with post-operative liver biopsy specimens. Mean CT-AVs after LDLT were decreased significantly from the pre-operative values, recovered to over 60 HU within 6 months. There was a positive linear correlation between the CT-AVs and the receptor index (LHL15) in technetium-99m-diethylenetriaminepenta-acetic acid-galactosyl-human serum albumin (99mTc-GSA) liver scintigraphy (r = 0.803, p = 0.005). The recipients were divided into two groups according to the CT-AV at one post-operative week (group H; ,55HU, group L; <55HU). The low CT-AVs, under 55 HU, in group L were prolonged for 3 months compared with those in group H (p < 0.05). The 1-year cumulative survival rate was 94.7% and 45.5% in groups H and L, respectively (p = 0.014). Histological findings revealed that the parenchymal damage was severe in the grafts with low CT-AVs. The CT-AVs in the grafts may be a useful parameter for assessing the allograft functional reserve. [source] Dietary vitamin C and E supplementation and reproduction of milkfish Chanos chanos ForsskalAQUACULTURE RESEARCH, Issue 7 2000A C Emata Milkfish Chanos chanos Forsskal broodstock (11 years old, average body weight 5.23,5.73 kg) reared in 10-m-diameter by 3-m-deep floating net cages (31,36 fish per cage) at SEAFDEC AQD's Igang Marine Substation in Guimaras Island, central Philippines, were fed daily at 3% of total body weight formulated diets (36% protein, 7,8% lipid) supplemented with 0.1% vitamin C, 0.05% vitamin E, both vitamin C and E or no vitamin supplementation (control) for 3 years. Reproductive performance was assessed in an attempt to determine the optimum nutrition for successful spawning of milkfish. The total egg production, mean number of eggs per spawning, number of spawns and mean egg diameter were not affected by dietary vitamin C and E supplementation. However, broodstock given dietary supplementation of vitamin C alone or in combination with vitamin E had a higher percentage of spawns with higher (> 90%) percentage egg viability, hatching and cumulative survival rate than those of the control. Broodstock given dietary vitamin E supplementation alone had few spawns, which made the results difficult to analyse. The results confirm the essentiality of vitamin C supplementation in producing more spawns with good egg and larval quality. The production of an adequate volume of good quality eggs and larvae to support hatchery operation is necessary to offset the huge investment in broodstock development, as it takes at least 5 years for milkfish to attain sexual maturation and spawning. [source] An intraductal papillary component is associated with prolonged survival after hepatic resection for intrahepatic cholangiocarcinoma,BRITISH JOURNAL OF SURGERY (NOW INCLUDES EUROPEAN JOURNAL OF SURGERY), Issue 1 2004Y. Tajima Background: The outcome after surgery for intrahepatic cholangiocarcinoma (ICC) is dismal and data on long-term survival are not available. This study evaluated prognostic indicators and characteristic features of long-term survivors after hepatic resection for ICC. Methods: Thirty-one patients who had undergone hepatic resection for ICC were studied. Univariate and multivariate survival analyses of clinicopathological data included an intraductal papillary carcinoma component (IDPCC) in the tumour, which was defined as the histological demonstration of cancer cells growing in a papillary fashion into the lumen of the large bile duct. Results: The overall cumulative survival rate after hepatic resection for ICC was 51·2 per cent at 1 year and 24·5 per cent at 5 years, with a mean(s.d.) survival time of 11(4) months. The presence of IDPCC (P = 0·003), curative resection (P = 0·009) and the absence of perineural invasion (P = 0·040) were identified as favourable independent prognostic factors in multivariate analysis. Eight patients with IDPCC had a 5-year survival rate of 87·5 per cent and a mean(s.d.) survival time of 69(13) months. All seven patients who survived for more than 5 years after surgery had IDPCC, regardless of the gross appearance of the tumour. Conclusion: An IDPCC in the tumour resulted in long-term survival after hepatic resection for ICC. Copyright © 2003 British Journal of Surgery Society Ltd. Published by John Wiley & Sons, Ltd. [source] Surgical treatment of recurrent endometrial carcinomaCANCER, Issue 1 2004Elio Campagnutta M.D. Abstract BACKGROUND Surgery does not have a definite role in the treatment of patients with recurrent endometrial carcinoma, except for those with central pelvic recurrences. The authors describe their experience with surgery in patients with abdominal endometrial recurrences. METHODS Between 1988 and 2000, 75 patients with abdominal and pelvic endometrial recurrences underwent secondary rescue surgery. Patients were classified according to the presence or absence of residual tumor after surgery. Therapy after rescue surgery was undertaken at the discretion of the medical oncologist. The progression-free interval and overall survival were defined as the time from secondary rescue surgery to the specific event and were evaluated by the Kaplan,Meier method and the log-rank test. A Cox proportional hazards regression model was used to compare survival with covariates. RESULTS Fifty-six patients (74.7%) underwent optimal debulking. Major surgical complications were observed in 23 patients (30.7%). Only 1 postoperative death was observed, although the mortality rate for surgical complications after the postoperative period was 8%. Patients who underwent optimal debulking had a significantly better cumulative survival rate compared with patients who had residual disease (36% vs. 0% at 60 months; P < 0.05). Residual disease, chemotherapy after rescue surgery, and central pelvis,vagina as the only site of recurrence were associated significantly with survival. CONCLUSIONS The authors found that this approach was very challenging in terms of the procedures involved, the incidence of major surgical complications, and the high mortality rate. It was useful in increasing overall survival, provided that patients were free of macroscopic disease. Careful selection of patients is needed to minimize mortality. Cancer 2004;100:89,96. © 2003 American Cancer Society. [source] Laser-Welded Titanium Frameworks Supported by Implants in the Partially Edentulous Mandible: A 10-Year Comparative Follow-Up StudyCLINICAL IMPLANT DENTISTRY AND RELATED RESEARCH, Issue 3 2008Anders Örtorp DDS, PhD/Odont Dr ABSTRACT Background: Comparative long-term knowledge of different framework materials in the partially edentulous implant patient is not available. Purpose: To report and compare 10-year data on free-standing implant-supported partial prostheses with laser-welded titanium (test) and conventional gold alloy (control) frameworks. Materials and Methods: Altogether, 52 partially edentulous patients were consecutively provided with laser-welded prostheses (n = 60) in the partially edentulous lower jaw (test group). A control group of 52 randomly selected patients with gold alloy castings (n = 60) was used for comparison. Clinical and radiographic 10-year data were retrospectively collected and evaluated for both groups. Results: The overall 10-year implant cumulative survival rate (CSR) was 93.0% (loaded implants, 96.4%), with a 10-year implant CSR of 91.5 and 94.7% for test and control implants, respectively (p > .05). Out of a total of 22 lost implants, 17 implants (77.3%) were shorter than 10 mm. The overall 10-year prosthesis CSR was 93.7%, with a corresponding 10-year CSR of 88.4 and 100% for test and control groups, respectively (p < .05). Average 10-year bone loss was 0.46 mm (SD 0.47) and 0.69 mm (SD 0.53) for the test and control groups (p < .001), respectively. Only 1% of the implants had >3 mm accumulated bone loss after 10 years. Altogether, 10 of the prostheses in both groups had implant component mechanical problems (8.3%). None of the frameworks or implants fractured, but more fractures of porcelain veneers were observed in the test group (p < .05). Conclusion: The protocol of implant treatment in the partially edentulous jaw functioned well during 10 years, although prosthodontic maintenance was required. However, laser-welded titanium frameworks presented more problems as compared with gold alloy frameworks. More loaded implants were lost (p < .05), and higher incidence of porcelain chipping was noted in the test group (p < .05). However, bone loss was on an average lower for the test group during the 10 years of follow-up (p < .001). [source] Short Implants Placed One-Stage in Maxillae and Mandibles: A Retrospective Clinical Study with 1 to 9 Years of Follow-UpCLINICAL IMPLANT DENTISTRY AND RELATED RESEARCH, Issue 1 2007Paulo Maló DDS ABSTRACT Background:, The use of short implants (7,8.5 mm) has historically been associated with lower survival rates than for longer implants. However, recent clinical studies indicate that short implants may support most prosthetic restorations quite adequately, but still clinical documentation is sparse. Purpose:, The purpose of this study was to report on the placement of short Brånemark implants, testing the hypothesis that short implants in atrophied jaws might give similar long-term implant survival rates as longer implants used in larger bone volumes. Materials and Methods:, This retrospective clinical study included 237 consecutively treated patients with 408 short Brånemark implants supporting 151 fixed prostheses. One hundred thirty-one of the implants were 7-mm long, and 277 were 8.5-mm long. Final abutments were delivered at the time of surgery, and final prostheses were delivered 4 to 6 months later. Results:, One hundred and twenty six of the 7-mm implants (96%) have passed the 1-year follow-up; 110 (84%), the 2-year follow-up; and 88 (67%), the 5-year follow-up. Five implants failed in four patients before the 6-month follow-up, giving a cumulative survival rate of 96.2% at 5 years. The average bone resorption was 1 mm (SD=0.6 mm) after the first year and 1.8 mm (SD=0.8 mm) after the fifth year of function. Two hundred sixty nine of the 8.5-mm implants (97%) have passed the 1-year follow-up; 220 (79%), the 2-year follow-up; and 142 (51%), the 5-year follow-up. Eight implants failed in seven patients before the 6-month follow-up, giving a cumulative survival rate of 97.1% at 5 years. The average bone resorption was 1.3 mm (SD=0.8 mm) after the first year and 2.2 mm (SD=0.9 mm) after the fifth year of function. Conclusions:, The cumulative survival rates of 96.2 and 97.1% at 5 years for implants of 7.0- and 8.5-mm length, respectively, indicate that one-stage short Brånemark implants used in both jaws is a viable concept. [source] A Prospective Clinical Study on Titanium Implants in the Zygomatic Arch for Prosthetic Rehabilitation of the Atrophic Edentulous Maxilla with a Follow-Up of 6 Months to 5 YearsCLINICAL IMPLANT DENTISTRY AND RELATED RESEARCH, Issue 3 2006Carlos Aparicio DDS ABSTRACT Background, Prosthetic rehabilitation with implant-supported prostheses in the atrophic edentulous maxilla often requires a bone augmentation procedure to enable implant placement and integration. However, a rigid anchorage can also be achieved by using so-called zygomatic implants placed in the zygomatic arch in combination with regular implants placed in residual bone. Purpose, The aim of the present study was to report on the clinical outcome of using zygomatic and regular implants for prosthetic rehabilitation of the severely atrophic edentulous maxilla. Materials and Methods, Sixty-nine consecutive patients with severe maxillary atrophy were, during a 5-year period, treated with a total of 69 fixed full-arch prostheses anchored on 435 implants. Of these, 131 were zygomatic implants and 304 were regular implants. Fifty-seven bridges were screw-retained and 12 were cemented. The screw-retained bridges were removed at the examination appointments and each implant was tested for mobility. In addition, the zygomatic implants were subjected to Periotest® (Siemens AG, Bensheim, Germany) measurements. The patients had at the time of this report been followed for at least 6 months up to 5 years in loading. Results, Two regular implants failed during the study period giving a cumulative survival rate of 99.0%. None of the zygomatic implants was removed. All patients received and maintained a fixed full-arch bridge during the study. Periotest measurements of zygomatic implants showed a decreased Periotest values value with time, indictating an increased stability. Three patients presented with sinusitis 14,27 months postoperatively, which could be resolved with antibiotics. Loosening of the zygomatic implant gold screws was recorded in nine patients. Fracture of one gold screw as well as the prosthesis occurred twice in one patient. Fracture of anterior prosthetic teeth was experienced in four patients. Conclusions, The results from the present study show that the use of zygomatic and regular implants represents a predictable alternative to bone grafting in the rehabilitation of the atrophic edentulous maxilla. [source] Fixed Implant-Supported Prostheses in Elderly Patients: A 5-Year Retrospective Study of 133 Edentulous Patients Older than 79 YearsCLINICAL IMPLANT DENTISTRY AND RELATED RESEARCH, Issue 4 2004Ingela Engfors DDS ABSTRACT Background: An increasing number of elderly patients are treated with implants, but results for the elderly patient in terms of implant success and adaptation to implant prostheses are contradictory. Objective: To retrospectively study the 5-year clinical and radiologic performances of fixed implant-supported prostheses placed in edentulous elderly patients and to compare those results with the results of using similar prostheses in a control group of younger patients. Materials and Methods: The study group comprised 133 edentulous patients who were 80 or more years of age and who were consecutively treated with fixed implant-supported prostheses between January 1986 and August 1998. Altogether 761 Brånemark System® implants (Nobel Biocare AB, Göteborg, Sweden) were placed in 139 edentulous jaws. The control group comprised 115 edentulous patients who were younger than 80 years and who were treated consecutively from March 1996 to November 1997 with similar prostheses. In this group 670 implants were placed in 118 edentulous jaws. Information was collected from all postinsertion visits, including the fifth annual checkup, and changes of marginal bone levels were analyzed from intraoral radiographs. Results: The 5-year cumulative survival rate (CSR) for implants in the maxilla was 93.0% in the study group and 92.6% in the control group; the corresponding CSRs for implants in the mandible were 99.5% and 99.7%. The most common complications for patients in the study group were soft tissue inflammation (mucositis) and cheek and lip biting (p < .05) whereas resin veneer fractures were the most common complications for the control group. Overall 5-year marginal bone loss for the study group was 0.7 mm (standard deviation [SD], 0.45) in the upper jaw and 0.6 mm (SD, 0.50) in the lower jaw. Differences in bone levels and bone loss between the two groups did not reach significant levels (p > .05). Conclusions: Implant treatment in the elderly patients showed treatment results comparable to those observed in younger age groups. However, indications of more problems with adaptation could be observed and were reflected in more postinsertion problems. Cleaning problems and associated soft tissue inflammation (mucositis) as well as tongue, lip, and cheek biting were significantly more often observed among the elderly patients (p < .05). [source] A 5-Year Prospective Follow-Up Study of Implant-Supported Fixed Prostheses in Patients Subjected to Maxillary Sinus Floor Augmentation with an 80:20 Mixture of Bovine Hydroxyapatite and Autogenous BoneCLINICAL IMPLANT DENTISTRY AND RELATED RESEARCH, Issue 2 2004Mats Hallman DDS ABSTRACT Background: Prospective long-term follow-up studies evaluating the use of bone substitutes to enable dental implant placement and integration are rare. Purpose: This study was undertaken to evaluate the survival rate of dental implants placed 6 months after maxillary sinus floor augmentation using a mixture of 80% bovine hydroxyapatite (BH) and 20% autogenous bone (AB). Material and Methods: Twenty patients subjected to 30 maxillary sinus floor grafting procedures using fibrin glue and an 80:20 mixture of BH and AB to enable placement of dental implants 6 months later were followed for 5 years of functional loading. Clinical and radiographic examinations of the grafts and implants were performed. Results: After 5 years of functional loading with fixed bridges, 15 of 108 implants had been lost, giving a cumulative survival rate of 86%. The mean marginal bone loss after 5 years was 1.3 ± 1.1 mm. Conclusion: Grafting of the maxillary sinus with a mixture of BH and AB and later placements of turned implants could be performed with predictable long-term results. All but one of the patients who were observed had functional fixed bridges after 5 years of functional loading. [source] Clinical Experiences of CNC-Milled Titanium Frameworks Supported by Implants in the Edentulous Jaw: 1-Year Prospective StudyCLINICAL IMPLANT DENTISTRY AND RELATED RESEARCH, Issue 1 2000Anders Örtorp LDS ABSTRACT Background: A new type of titanium framework has been introduced, but so far no clinical reports have been made in this treatment modality. Purpose: The aim of this study was to report the clinical performance of implant-supported prostheses with computer numeric controlled (CNC)-milled titanium frameworks in the edentulous jaw and to compare the results with prostheses provided with conventional cast frameworks during the first year of function. Material and Methods: A consecutive group of 65 patients with 67 prostheses were provided with CNC-milled titanium frameworks in 23 upper and 44 lower jaws. During the same period, 61 consecutive patients were treated on a routine basis with 31 upper and 31 lower conventional gold alloy casting prostheses. Clinical and radiographic 1-year data were collected for both the test and control groups. Results: A total of 14 of 729 inserted implants were lost during the follow-up period (1.9%). All prostheses were functioning after 1 year except a conventional prosthesis with a cast framework, which was replaced by an implant-supported over-denture due to implant loss. The 1-year cumulative survival rate (CSR) was 100% and 97.8% for CNC prostheses and implants, respectively. The corresponding CSR for the control group was 98.3% and 98.3%, respectively. Few problems were reported in both groups, and the clinical and the radiologic performances were similar for both groups. No mechanical complications except some resin veneer fractures (n = 6) were observed. The mean marginal bone loss for the test group during the first year in function was 0.4 mm (SD = 0.35) and 0.4 mm (SD = 0.33) in the upper and lower jaws, respectively. A similar pattern of bone reaction was also observed in the control group. Conclusion: CNC-milled titanium frameworks can be used as an alternative to conventional castings in the edentulous jaw, presenting similar clinical and radiologic performances as conventional cast frameworks during the first year of function. [source] A systematic review of the survival and complication rates of implant supported fixed dental prostheses with cantilever extensions after an observation period of at least 5 yearsCLINICAL ORAL IMPLANTS RESEARCH, Issue 5 2009Marco Aglietta Abstract Objective: The aim of this systematic review was to assess the survival rates of short-span implant-supported cantilever fixed dental prostheses (ICFDPs) and the incidence of technical and biological complications after an observation period of at least 5 years. Material and methods: An electronic MEDLINE search supplemented by manual searching was conducted to identify prospective or retrospective cohort studies reporting data of at least 5 years on ICFDPs. Five- and 10-year estimates for failure and complication rates were calculated using standard or random-effect Poisson regression analysis. Results: The five studies eligible for the meta-analysis yielded an estimated 5- and 10-year ICFDP cumulative survival rate of 94.3% [95 percent confidence interval (95% CI): 84.1,98%] and 88.9% (95% CI: 70.8,96.1%), respectively. Five-year estimates for peri-implantitis were 5.4% (95% CI: 2,14.2%) and 9.4% (95% CI: 3.3,25.4%) at implant and prosthesis levels, respectively. Veneer fracture (5-year estimate: 10.3%; 95% CI: 3.9,26.6%) and screw loosening (5-year estimate: 8.2%; 95% CI: 3.9,17%) represented the most common complications, followed by loss of retention (5-year estimate: 5.7%; 95% CI: 1.9,16.5%) and abutment/screw fracture (5-year estimate: 2.1%; 95% CI: 0.9,5.1%). Implant fracture was rare (5-year estimate: 1.3%; 95% CI: 0.2,8.3%); no framework fracture was reported. Radiographic bone level changes did not yield statistically significant differences either at the prosthesis or at the implant levels when comparing ICFDPs with short-span implant-supported end-abutment fixed dental prostheses. Conclusions: ICFDPs represent a valid treatment modality; no detrimental effects can be expected on bone levels due to the presence of a cantilever extension per se. [source] Prosthetic treatment of maxillary lateral incisor agenesis with osseointegrated implants: a 24,39-month prospective clinical studyCLINICAL ORAL IMPLANTS RESEARCH, Issue 1 2006Fernando Zarone Abstract Objectives: The present study aimed at evaluating the marginal bone resorption and the peri-implant tissue conditions around Narrow-Neck ITI implants in the implant,prosthetic treatment of the agenesis of maxillary lateral incisors. Material and methods: Thirty patients affected by monolateral or bilateral agenesis of the maxillary lateral incisors were selected. Thirty-four ITI-SLA Narrow Neck implants were inserted and loaded about 4 months after the surgical procedure. The final restorations were realized using Aureo Galvan Crowns veneered with feldspathic ceramics. The follow-up period ranged from 24 to 39 months. Both marginal bone resorption and soft tissue quality were evaluated. The data were statistically analysed using analysis of variance (ANOVA) for repeated measures, one-way ANOVA and Tukey's post hoc test (P=0.05). Results: During the 24,39-month follow-up period, no implant showed either pain and sensitivity or mobility. After 39 months of functional loading, a cumulative survival rate of 97.06% and a cumulative success rate of 94.12% were calculated. Conclusions: In case of maxillary lateral incisor agenesis, the implant,prosthetic approach has proved to be a reliable and predictable treatment for both re-establishment of function and aesthetics. Satisfactory values of marginal bone resorption over time and optimal conditions of peri-implant tissue around Narrow-Neck ITI implants were found. [source] Therapy of peri-implantitis with resective surgeryCLINICAL ORAL IMPLANTS RESEARCH, Issue 1 2005A 3-year clinical trial on rough screw-shaped oral implants. Abstract: The purpose of this randomized clinical trial was to compare the clinical outcome of two different surgical approaches for the treatment of peri-implantitis. Seventeen patients with ITI® implants were included consecutively over a period of 5 years. The patients were randomized with a lottery assignment. Ten patients were treated with resective surgery and modification of surface topography (test group). The remaining seven patients were treated with resective surgery only (control group). Clinical parameters (suppuration, modified plaque index , mPI, modified bleeding index , mBI, probing pocket depth , PPD, pseudopocket , DIM, mucosal recession , REC, probing attachment level , PAL) were recorded at baseline, as well as 6, 12, 24 and 36 months after treatment. The cumulative survival rate for the implants of the test group was 100% after 3 years. After 24 months, two hollow-screw implants of control group were removed because of mobility. Consequently, the cumulative survival rate was 87.5%. The recession index in the control group was significantly lower than in the test group at 24 months (Student's t -value of ,2.14). On the contrary, control group showed higher PPD, PAL and mBI indexes than test group (Student's t -values of +5.5, +2.4 and +9.61, respectively). The PPD and mBI indexes for the implants of the control group were significantly higher at baseline than 24 months later (Student's t -values of +3.18 and +3.33, respectively). Recession and PAL indexes resulted in values significantly lower than baseline (Student's t -values of ,4.62 and ,2.77, respectively). For the implants of the test group PPD and mBI indexes were significantly higher at baseline than 36 months after (Student's t -values of +11.63 and +16.02, respectively). Recession index resulted in values significantly lower at baseline (Student's t -value of ,5.05). No statistically significant differences were found between PAL index measurement at baseline and 36 months later (Student's t -value of +0.89). In conclusion, resective therapy associated with implantoplasty seems to influence positively the survival of oral implants affected by inflammatory processes. Résumé Le but de cet essai clinique randomisé a été de comparer la guérison clinique de deux approches chirurgicales différentes pour le traitement de la paroïmplantite. Dix-sept patients avec des implants ITI® ont été inclus dans cette étude durant une période de cinq années. Les patients étaient répartis au hasard. Dix patients étaient traités avec une chirugie de résection et une modification de la topographie de surface (groupe test). Les derniers sept patients ont été traités avec la chirurgie de résection seulement (groupe contrôle). Des paramètres cliniques [suppuration, indice de plaque modifiée (mPI), indice de saignement modifié (mBI), profondeur de poche au sondage (PPD), pseudo poches (DIM), récession de la muqueuse (Rec), niveau d'attache au sondage (PAL)] ont été mesurés lors de l'examen initial et après six, douze, 24 et 36 mois. Le taux cumulatif pour les implants dans le groupe test était de 100% après trois années. Après 24 mois, deux implants vis creux du groupe contrôle ont été enlevés à cause de la mobilité. En conséquence, le taux de survie cumulatif était de 87,5%. L'indice de récession dans le groupe contrôle était significativement inférieur à celui du groupe test à 24 mois (valeur du test T de Student ,2,14). Par contre le groupe contrôle montrait des indices plus importants de PPD, PAL et mBI que le groupe test (valeurs du test T de Student respectivement de+5,50,+2,40,+9,61). Les indices PPD et mBI pour les implants du groupe contrôle étaient significativement plus importants lors de l'examen initial que 24 mois plus tard (valeurs du test T de Student respectivement de+ 3,18 et+3,33). Les indices de récession et de PAL résultaient en indices significativement inférieures que lors de l'examen initial (valeurs du test T de Student respectivement de ,4,62, ,2,77). Pour les implants du groupe test, les indices PPd et mBI étaient significativement plus importants lors de l'examen initial que 36 mois plus tard (valeurs du test T de Student respectivement de+11,63, 16,02). L'indice de récession résultait en indice significativement inférieur lors de l'examen initial (valeurs du test T de Student ,5,05). Aucune différence significative n'a été trouvée pour la mesure de l'indice PAL entre l'examen initial et 36 mois (valeur du test T de Student de+0,89). En conclusion, le traitement de résection associéà une plastieimplantaire semble influencer de manière positive la survie des implants dentaires affectés par les processus infectieux. Zusammenfassung Das Ziel dieser randomisierten klinischen Studie war, die klinischen Resultate von zwei verschiedenen chirurgischen Behandlungsvarianten der Periimplantitis zu vergleichen. Man nahm während einer Zeitdauer von fünf Jahren 17 Patienten mit ITI®-Implantaten fortlaufend in die Studie auf. Mit einem lotterieartigen System teilte man die Patienten zufällig auf. 10 der Patienten erhielten eine resektive Chirurgie und man modifizierte zusätzlich die Implantatoberfläche (Testgruppe). Bei den übrigen 7 wandte man ausschliesslich die resektive Chirurgie an (Kontrollgruppe). Zu Beginn sowie 6, 12, 24 und 36 Monate nach der Behandlung erhob man folgende klinischen Parameter: Eiterung, modifizierter Plaqueindex , mPI, modifizierter Blutungsindex , mBI, Sondierungstiefe , PPD, Pseudotaschen , DIM, Mukosarezession , Rec, sondierbares Attachmentniveau , PAL. Die kumulative Überlebensrate der Implantate in der Testgruppe betrug nach 3 Jahren 100%. Nach 24 Monaten mussten infolge Mobilität 2 Hohlschraubenimplantate der Kontrollgruppe entfernt werden. Daher betrug die kumulative Überlebensrate hier 87.5%. Der Rezessionsindex nach 24 Monaten war in der Kontrollgruppe signifikant tiefer als in der Testgruppe (T-Student Wert ,2.14). Dagegen zeigte die Kontrollgruppe höhere Indices bei der PPD, dem PAL und beim mBI als die Testgruppe (T-Student Werte von +5.5/+2.4 und +9.61). Die PPD und die mBI-Indices der Implantate aus der Kontrollgruppe waren zu Beginn signifikant höher als 24 Monate später (T-Student Werte von +3.18 und +3.33). Die Rezessions- und PAL-Indices waren dagegen signifikant tiefer als zu Beginn (T-Student Werte von ,4.62 und ,2.77). Bei den Implantaten der Testgruppe waren die PPD- und mBI-Indices zu Beginn signifikant höher als nach 36 Monaten (T-Student Werte von +11.63 und +16.02). Der Rezessionsindex war bei Studienbeginn signifikant tiefer (T-Student Wert von ,5.05). Bei den Messungen des PAL-Index konnte man zwischen den Anfangswerten und denjenigen nach 36 Monaten keine statistisch signifikanten Unterschiede erkennen (T-Student Wert von +0.89). Zusammenfassend kann man feststellen, dass eine resektive Therapie verbunden mit einer Oberflächenveränderung, die Überlebensrate der von einem entzündlichen Prozess betroffenen Implantate positiv zu beeinflussen vermag. Resumen El propósito de este estudio clínico aleatorio fue comparar los resultados clínicos de dos enfoques quirúrgicos diferentes para el tratamiento de periimplantitis. Se incluyeron a diecisiete pacientes consecutivos con implantes ITI® durante un periodo de cinco años. Los pacientes se asignaron aleatoriamente por medio de un sistema de lotería. Se trató a diez pacientes con cirugía resectiva y modificación de la topografía de superficie (grupo de prueba). Los siete pacientes restantes se trataron con cirugía resectiva solamente (grupo de control). Se recogieron parámetros clínicos (supuración, índice de placa modificado , mPI, índice de sangrado modificado , mBI, profundidad de sondaje de la bolsa , PPD, pseudobolsa , DIM, recesión mucosa , REC, nivel de inserción al sondaje , PAL) al inicio, al igual que a los 6, 12, 24 y 36 meses tras el tratamiento. El índice acumulativo de éxito del grupo de prueba tras 3 años fue del 100%. A los 24 meses se retiraron dos implantes huecos roscados del grupo de control debido a movilidad. Consecuentemente el índice acumulado de supervivencia fue del 87.5%. El índice de recesión en el grupo de control fue significativamente más bajo que en el grupo de prueba a los 24 meses (valor T-student de ,2.14). Por el contrario, el grupo de control mostró unos índices PPD, PAL y mBI mas altos que en el grupo de prueba (valores de T-student de +5.5 +2.4 y +9.61 respectivamente). Los índices PPD y mBI para los implantes del grupo de control fueron significativamente mas altos al inicio que 24 meses mas tarde (valores de T-student de +3.18 y +3.33 respectivamente). Los índices de recesión y PAL resultaron significativamente mas bajos que al inicio (valores de T-student de ,4.62 y ,2.77 respectivamente). Para los implantes del grupo de prueba los índices PPD y mBI fueron significativamente mas altos al inicio que tras 36 meses (valores de T-student de +11.63 y +16.02 respectivamente). El índice de recesión resultó ser significativamente más bajo al inicio (valores de T-student de ,5.05). No se encontraron diferencias estadísticamente significativas para las mediciones de índice de PAL al inicio y 36 meses mas tarde (valores de T-student de +0.89). En conclusión, la terapia resectiva asociada con implantoplastia parece influir positivamente sobre la supervivencia de los implantes orales afectados por procesos inflamatorios. [source] Single-tooth replacement by immediate implant and connective tissue graft: a 1,9-year clinical evaluationCLINICAL ORAL IMPLANTS RESEARCH, Issue 3 2004Andrea E. Bianchi Abstract Objectives: The aim of the present study was to evaluate the long-lasting efficacy of a combined surgical protocol, using immediate implant and subepithelial connective tissue graft for single-tooth replacement. The advantages of this single-center, longitudinal, randomized, blind examiner research were the following: preservation of both keratinized mucosa amount and bone tissue, optimal peri-implant marginal sealing, satisfactory aesthetic results, reduction in treatment time. Materials and methods: In the time period from 1990 to 1998, 116 patients were consecutively admitted for treatment with a total of 116 solid screw ITI-implants supporting single crowns. Ninety-six patients underwent the proposed combined treatment (test group), while 20 received only single immediate implants (control group). The observation time extended from 1 up to 9 years. Results: The 9-year cumulative survival rate was 100% for both test and control groups. Comparative statistical analysis of soft and hard tissue peri-implant parameters demonstrated better results in the test group than in the control during every single 3-year analysis and especially in the last observation interval. The test group also showed very good results in terms of aesthetic parameters, which estimated the keratinized mucosa width, the alignment of crown emergence profile and the patient's satisfaction. Conclusion: Single-tooth replacement by immediate solid screw ITI implants in association with connective tissue autograft was demonstrated to be a predictable procedure. Moreover, this treatment can be considered as a sure system to reach an excellent functional and harmonious aesthetic restoration. Résumé Le but de l'étude présente a été d'évaluer l'efficacitéà long terme d'un protocole chirurgical combiné utilisant l'implant placé immédiatement et un greffon tissulaire de tissu conjonctif sous-épithélial pour le remplacement d'une dent unique. Les avantages de cette recherche randomisée longitudinale dans un seul centre et en aveugle étaient les suivants : préservation de la quantité de muqueuse kératinisée et du tissu osseux, une fermeture marginale paroïmplantaire optimale, des résultats esthétiques satisfaisants et une réduction du temps de traitement. Durant les années 1990 à 1998, 116 patients ont été admis pour le traitement de 116 implants ITI en vis pleines portant des couronnes uniques. Nonante-six patients ont recu le traitement proposé (groupe test) tandis que 20 autres n'ont reçu que des implants placés immédiatement en une étape (groupe contrôle). Le temps d'observation s'échelonnait de un à neuf ans. Le taux de survie cumulatif à neuf années était de 100% dans les deux groupes. L'analyse statistique comparative des tissus mous et durs paroïmplantaires a constaté des meilleurs résultats dans le groupe test que dans le groupe contrôle durant chaque analyse de trois ans et spécialement dans la dernière période d'observation. Le groupe test montrait également de très bons résultats esthétiques concernant la largeur de la muqueuse kératinisée, l'alignement du profil de l'émergence de la couronne et la satisfaction du patient. Le remplacement de dents uniques par des implants ITI en vis pleines placées immédiatement en association avec une greffe de tissu conjonctif est un processus prévisible. De plus, ce traitement peut être considéré comme un système sûr pouvant apporter une restauration fonctionnelle harmonieuse et esthétique. Zusammenfassung Ziele: Das Ziel dieser Studie war es, den Langzeiterfolg eines chirurgischen Protokolls zu untersuchen, das den Einzelzahnersatz mit einem Sofortimplantat in Kombination mit einem subepithelialen Bindegewebstransplantat vorsah. Die Vorteile dieser an einem Zentrum durchgeführten randomisierten, longitudinalen Blindstudie waren die folgenden: Erhaltung sowohl der gesamten keratinisierten Mukosa wie auch des Knochengewebes, der optimale perimplantäre marginale Abschluss, die befriedigenden ästhetischen Resultate und die Verkürzung der Behandlungszeit. Material und Methoden: In der Zeit von 1990 bis 1998 bekamen in der Folge 116 Patienten insgesamt 116 ITI-Vollschraubenimplantate, die mit Einzelkronen versorgt wurden. 96 Patienten wurden nach der vorgestellten kombinierten Methode behandelt (Testgruppe), währenddem die übrigen 20 Patienten einzig das Sofortimplantat erhielten (Kontrollgruppe). Die Beobachtungszeit reichte von 1 bis zu 9 Jahren. Resultate: Die kumulative Überlebensrate nach 9 Jahren betrug für Test- und Kontrollgruppe 100%. Eine statistische Vergleichsanalyse der Parameter von Weich- und Hartgeweben zeigte während jeder der dreijährigen Beobachtungsphasen (insbesondere in der letzten) in der Testgruppe bessere Resultate als in der Kontrollgruppe. Die Testgruppe zeigte auch bezüglich ästhetischen Parametern (Breite der keratinisierten Gingiva, Lokalisation der Durchtrittsstelle der Krone, Zufriedenheit des Patienten) sehr schöne Resultate. Zusammenfassung: Der Einzelzahnersatz mittels Sofortimplantation einer ITI-Vollschraube in Verbindung mit einem freien Bindegewebetransplantat erwies sich als gut beherrschbare Methode. Man kann diese Behandlung sogar als sicher für den Erhalt einer hervorragenden funktionellen, harmonischen und ästhetischen Rekonstruktion empfehlen. Resumen Objetivos: La intención del presente estudio fue evaluar la eficacia a largo plazo de un protocolo quirúrgico combinado, usando implantes inmediatos e injertos de tejido conectivo subepitelial para reemplazar dientes unitarios. Las ventajas de esta investigación unicentro, longitudinal, aleatoria, examinador ciego fueron las siguientes: preservación de tanto de la cantidad de mucosa queratinizada como del tejido óseo, sellado marginal periimplantario óptimo, resultados estéticos satisfactorios, reducción del tiempo del tratamiento. Material y métodos: En el periodo de tiempo desde 1990 a 1998, se admitieron 116 pacientes consecutivos para tratamiento con un total de 116 implantes macizos roscados ITI soportando coronas unitarias. Noventa y seis pacientes se sometieron al tratamiento propuesto (grupo de prueba), mientras 20 recibieron solo implantes inmediatos unitarios (grupo de control). El tiempo de observación se extendió de 1 9 años. Resultados: El índice acumulado de supervivencia a los 9 años fue del 100% tanto para el grupo de prueba como el de control. El análisis estadístico comparativo de los parámetros de los tejidos blandos y duros periimplantarios demostró mejores resultados en el grupo de prueba que en el de control, durante cada análisis de 3 años y especialmente en el último intervalo de observación. El grupo de prueba también mostró muy buenos resultados en términos de parámetros estéticos, que estimaron la anchura de la mucosa queratinizada, la alineación del perfil de emergencia de la corona y la satisfacción del paciente. Conclusión: La sustitución de un diente unitario por implantes macizos roscados inmediatos ITI en asociación con autoinjertos de tejido conectivo demostró ser un procedimiento predecible. Más aun, este tratamiento puede ser considerado como un sistema seguro para alcanzar una excelente restauración estética funcional y armónica. [source] Effect of being overweight on postoperative morbidity and long-term surgical outcomes in proximal gastric carcinoma,JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Issue 3 2009Sung Jin Oh Abstract Background and Aim:, The prevalence of being overweight has risen remarkably in Korea. This study sought to clarify the relationship between being overweight and surgical outcomes in gastric cancer patients. Methods:, A total of 410 patients who underwent curative total gastrectomies with D2 dissection from January 2000 to December 2003 were retrospectively studied from a prospectively designed database. The patients were assigned to two groups based upon their body mass index (BMI): non-overweight, BMI < 25 kg/m2; overweight, BMI , 25 kg/m2. Perioperative surgical outcomes, postoperative morbidity, mortality, recurrence, and prognosis were analyzed. Results:, The overweight group had longer operation time and more postoperative complications than the non-overweight group. The two groups were similar in terms of transfusion volumes, postoperative bowel movement, time to initiation of a soft diet, and postoperative hospital stay. Patterns of recurrence and cumulative survival rates were similar for each group. Multivariate analysis showed that being overweight was not a risk factor for recurrence or poor prognosis. Conclusion:, Although being overweight was associated with increased operation time and higher risk of complications in gastric cancer patients undergoing curative total gastrectomy, it had no effect on recurrence or long-term survival. [source] A retrospective analysis of 1000 consecutively placed implants in private practiceAUSTRALIAN DENTAL JOURNAL, Issue 2 2009KC Nixon Abstract Background:, There have been numerous reports evaluating clinical outcomes of implants placed in institutional settings, but there are few studies relating to implants placed in private practice. The aim of this retrospective study was to analyse the clinical outcomes of 1000 consecutively placed Straumann implants in private specialist periodontal practice. Methods:, A hand-search of patient records was undertaken to identify 1000 consecutively placed implants. Data extracted included patient demographics, details of implants placed, implant sites, timing of placement after extraction, hard and soft tissue augmentation procedures, loading protocols, type of prostheses and treatment outcomes (implant survival, implant success and complications). Results:, The majority of implants (71.5 per cent) placed in patients aged 40 to 69, and the majority of patients (88.6 per cent) received 1 or 2 implants. During the period of the study, 9 implants were lost and 45 presented with complications requiring chairside intervention. A life table analysis showed 5 and 10-year cumulative survival rates of 99.2 per cent and 98.4 per cent respectively, and 5 and 10-year cumulative success rates of 93.1 per cent and 90.9 per cent respectively. Conclusions:, With careful treatment planning and adherence to recommended surgical and prosthetic protocols, high implant survival and success rates can be achieved in a private practice setting. [source] Hepatocellular carcinoma with main portal vein tumor thrombusCANCER, Issue 6 2009Treatment with 3-dimensional conformal radiotherapy after portal vein stenting, transarterial chemoembolization Abstract BACKGROUND: Hepatocellular carcinoma (HCC) with main portal vein tumor thrombus (MPVTT) is often associated with poor prognosis. We retrospectively assessed the effectiveness of percutaneous transhepatic portal vein stenting and transarterial chemoembolization (PTPVS-TACE) combined with or without 3-dimensional conformal radiotherapy (3-DCRT) for HCC with MPVTT. METHODS: Forty-five patients with HCC complicated by MPVTT were treated with PTPVS-TACE. Among them, 16 patients (group A) received 3-DCRT with 30-60Gy as daily 2Gy fractions. The remaining 29 patients (group B) received no radiotherapy. The tumor responses, complications, stent patency rates, and cumulative survival rates were evaluated, and the Kaplan-Meier method and log-rank test were used for survival analysis. RESULTS: No severe complications were associated with PTPVS-TACE and 3-DCRT. The objective response rate (CR and PR) was 35.6%. The 60-, 180-, and 360-day cumulative stent patency rates were 93.3%, 62.2%, and 34.6% in group A, and 58.6%, 21.7%, and 10.8% in group B, respectively, showing significant difference between the 2 groups (P < .01). The mean patency time was 475.20 ± 136.97 and 199.58 ± 61.40 days, respectively. The 60-, 180-, and 360-day cumulative survival rates were 93.8%, 81.3%, and 32.5%, respectively, for group A, 86.2%, 13.8%, and 6.9%, respectively, for group B. Significant statistical differences were detected between the 2 groups (P < .01). CONCLUSIONS: These findings suggest that sequential therapy by PTPVS-TACE-3-DCRT is possibly an effective treatment modality for HCC complicated by main portal vein tumor thrombus. Cancer 2009. © 2009 American Cancer Society. [source] Viral load is a significant prognostic factor for hepatitis B virus-associated hepatocellular carcinomaCANCER, Issue 10 2002Kazuaki Ohkubo M.D. Abstract BACKGROUND Hepatitis B virus (HBV) is closely linked to hepatocellular carcinoma (HCC). The objective of the current study was to identify the factors involved in the prognosis of patients with HBV-associated HCC using multivariate analysis. METHODS The current study included 74 patients with HBV-associated HCC who were admitted to Nagasaki University Hospital, Nagasaki, Japan, between 1983,1998. Of these, 13 patients underwent surgical tumor resection; 43 patients received nonsurgical treatment with transcatheter arterial embolization, percutaneous ethanol injection, or both; and 18 patients were followed without any active treatment. The significance of the patient's age; gender; history of blood transfusion; alcohol use; serum levels of alanine aminotransferase, ,-fetoprotein, and HBV-DNA; number and size of liver tumors; clinical stage; and histologic diagnosis of HCC as prognostic factors was evaluated using univariate and multivariate analyses. RESULTS The 3-year, 5-year, and 10-year postdiagnosis cumulative survival rates were 36%, 21%, and 17%, respectively. Multivariate analysis identified the level of serum HBV-DNA and tumor size at diagnosis as independent and significant prognostic factors (P = 0.0022 and P = 0.0106, respectively). In addition, a low level of viremia was found to be associated with longer survival (P = 0.0057) even in patients who were negative for the hepatitis B e antigen. CONCLUSIONS The results of the current study suggest that viral load is a useful prognostic marker for HBV-related HCC and that HCC patients with a less favorable course appear either to clear the virus poorly or to have a greater level of virus production. Cancer 2002;94:2663,8. © 2002 American Cancer Society. DOI 10.1002/cncr.10557 [source] Turned Brånemark System® Implants in Wide and Narrow Edentulous Maxillae: A Retrospective Clinical StudyCLINICAL IMPLANT DENTISTRY AND RELATED RESEARCH, Issue 2 2008Bertil Friberg DDS ABSTRACT Background: The available jawbone volume is regarded as one of the most important factors when assessing the prognosis of oral implants in the rehabilitation of the edentulous maxilla. Purpose: The aim of the current investigation was to retrospectively evaluate and compare the outcome of implants placed in edentulous maxillae with either wide or narrow jaw shapes. The marginal bone loss and implant cumulative survival rates (CSRs) were calculated and analyzed with special reference to smoking habits. Materials and Methods: The study included 75 individuals with edentulous maxillae, of which 33 patients exhibited wide (group A) and 42 patients exhibited narrow jaw shapes (group B). A total of 506 turned Brånemark System® (Nobel Biocare AB, Göteborg, Sweden) implants were inserted (226 in group A and 279 in group B) and followed clinically up to 7 years. Smoking habits were recorded. Radiographs were obtained at connection of prostheses, and at the 1- and 5-year follow-up visit. The marginal bone loss was calculated for the groups and analyzed using t -test. Results: Twenty-eight implants were lost during the study period, revealing implant CSRs at 7 years of 94.6% (11/226) and 93.6% (17/279) for wide and narrow crests, respectively. No difference in marginal bone loss was seen between the two groups, although a trend toward more bone loss was recorded for patients with wide crests. Smoking habits were more common in group A (45%) than in group B (31%). During the first year of function, smokers lost significantly more marginal bone than nonsmokers (p = .0447), albeit this difference did not prevail (p > .05) at the end of the study period. Conclusions: The implant CSRs at 7 years were equally good for the two groups of patients with various jaw shapes. Initially, smokers showed significantly more marginal bone loss than nonsmokers. [source] | |||||||||||||||||||||||||